Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amideOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how surgery-induced gut microbial dysbiosis contributes to perioperative neurocognitive disorders (PND), a common but poorly treated postoperative complication. The researchers investigated the mechanisms linking postoperative changes in the gut microbiota to disruptions in intestinal barrier function, serum metabolism, and cognitive outcomes. Behavioral testing, 16S rRNA gene sequencing, non-target metabolomics, intestinal permeability assays, protein analysis, and immunofluorescence staining were used to trace this gut-brain pathway. The metabolite palmitic amide was identified as a specific link between microbial changes and cognitive effects.
Who was studied?
The study was conducted in mice, comparing aged and young animals subjected to surgery. Aged mice were the primary focus, since surgery-induced cognitive impairment occurred predominantly in this group. Interventions including fecal microbiota transplantation from young donors, dexamethasone, Lactobacillus supplementation, indole propionic acid, and palmitic amide administration were tested in these mouse models.
What were the most important findings?
Surgery altered gut microbiota composition and worsened intestinal barrier disruption specifically in aged mice, which corresponded with the cognitive impairment seen mainly in this group. These adverse effects could be reduced by transferring microbiota from young donors or by strengthening intestinal barrier function with dexamethasone, Lactobacillus, or indole propionic acid. The abstract also points to microbiota-linked changes in metabolism, including the metabolite palmitic amide, as part of the mechanism connecting gut dysbiosis to cognitive outcomes.
What are the greatest implications of this study?
The findings suggest that age-related vulnerability to postoperative cognitive decline may be driven in part by how surgery disrupts the gut microbiota and intestinal barrier. Because microbiota transfer, probiotic supplementation, and metabolite-targeted interventions each improved outcomes in this model, gut-directed strategies could represent a therapeutic avenue for PND. This supports viewing perioperative cognitive complications through a gut-brain axis lens rather than treating them as purely neurological events.